NCT01511133View on ClinicalTrials.gov

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Rotavirus InfectionEvidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants
Interventions
PROCEDURE

Stool sample

Stool samples collected at pre-determined time points in previous studies will be analysed to detect the presence of PCV-1 DNA and pattern of detection.

PROCEDURE

Serum sample

Serum samples collected at pre and post vaccination time points in previous studies will be assessed for Anti-PCV-1 antibody.

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01511133 - Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™ | Biotech Hunter | Biotech Hunter